New hope for stomach and bowel cancers: experimental drug SKB571 enters Mid-Stage trial
NCT ID NCT07564466
First seen May 08, 2026 · Last updated May 08, 2026
Summary
This study tests an experimental drug called SKB571 in 120 adults with gastrointestinal tumors (cancers of the stomach, intestines, or related organs). The main goal is to see if the drug shrinks tumors and to check for side effects. Participants must have measurable tumors and be in good overall health. The study is not yet recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTROINTESTINAL TUMORS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cancer Hospital of Shandong First Medical University
Jinan, Shandong, 250117, China
-
Chongqing University Three Gorges Hospital
Chongqing, Chongqing Municipality, 404000, China
-
Fujian Cancer Hospital
Fuzhou, Fujian, 350014, China
-
Henan Cancer Hospital
Zhengzhou, Henan, 450008, China
-
Hunan Cancer Hospital
Changsha, Hunan, 410013, China
-
Jiangsu Cancer Hospital
Nanjing, Jiangsu, 210009, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210029, China
-
Jiangxi Cancer Hospital
Nanchang, Jiangxi, 3300029, China
-
Renji Hospital, Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, 200127, China
-
Shandong Provincial Hospital
Jinan, Shandong, 250021, China
-
Shanxi Provincial Cancer Hospital
Taiyuan, Shanxi, 030013, China
-
Sichuan Cancer Hospital
Chengdu, Sichuan, 610041, China
-
Sun Yat-sen University Cancer Center
Guangzhou, Guangdong, 510060, China
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, 471003, China
-
The First Affiliated Hospital of Xiamen University
Xiamen, Fujian, 361003, China
-
The First Affiliated Hospital of Zhengzhou University
Zhengzhou, Henan, 450052, China
-
The First Hospital of China Medical University
Shenyang, Liaoning, 110001, China
-
The First Hospital of Jilin University
Changchun, Jilin, 130021, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
-
The People's Hospital of Guangxi Zhuang Autonomous Region
Nanning, Guangxi, 530021, China
-
The Second Affiliated Hospital of Nanchang University
Nanchang, Jiangxi, 330006, China
-
The Second Affiliated Hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710004, China
-
The Sixth Affiliated Hospital, Sun Yat-sen University
Guangzhou, Guangdong, 510655, China
-
Tianjin Medical University Cancer Institute & Hospital
Tianjin, Tianjin Municipality, 300060, China
-
Tumor Hospital of Harbin Medical University
Harbin, Heilongjiang, 150081, China
Conditions
Explore the condition pages connected to this study.